These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 22561769)

  • 1. Evaluation of transurethral ethanol ablation of prostate for symptomatic benign prostatic hyperplasia.
    Faruque MS; Alam MK; Ullah MA; Rahman MH; Kibria MG; Haque MM; Haque MA; Joarder AI; Paul BK
    Mymensingh Med J; 2012 Apr; 21(2):265-9. PubMed ID: 22561769
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transurethral ethanol injection therapy of benign prostatic hyperplasia: four-year follow-up.
    Sakr M; Eid A; Shoukry M; Fayed A
    Int J Urol; 2009 Feb; 16(2):196-201. PubMed ID: 19054163
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urodynamic effects of transrectal intraprostatic Ona botulinum toxin A injections for symptomatic benign prostatic hyperplasia.
    de Kort LM; Kok ET; Jonges TN; Rosier PF; Bosch JL
    Urology; 2012 Oct; 80(4):889-93. PubMed ID: 22854138
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of ultrasound-guided transrectal ethanol injection for the treatment of benign prostatic hyperplasia in patients with high-risk comorbidities: a long-term study at a single tertiary care institution.
    Li Y; Zhao Q; Dong L
    Urology; 2014 Mar; 83(3):586-91. PubMed ID: 24581519
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ethanol injection therapy of the prostate for benign prostatic hyperplasia: preliminary report on application of a new technique.
    Goya N; Ishikawa N; Ito F; Ryoji O; Tokumoto T; Toma H; Yamaguchi Y
    J Urol; 1999 Aug; 162(2):383-6. PubMed ID: 10411043
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase I/II examination of transurethral ethanol ablation of the prostate for the treatment of symptomatic benign prostatic hyperplasia.
    Plante MK; Marks LS; Anderson R; Amling C; Rukstalis D; Badlani G; Getlin L; Vang E
    J Urol; 2007 Mar; 177(3):1030-5; discussion 1035. PubMed ID: 17296405
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the transurethral ethanol ablation of the prostate (TEAP) for symptomatic benign prostatic hyperplasia (BPH): a European multi-center evaluation.
    Grise P; Plante M; Palmer J; Martinez-Sagarra J; Hernandez C; Schettini M; Gonzalez-Martin M; Castiñeiras J; Ballanger P; Teillac P; Rolo F; Baena V; Erdmann J; Mirone V
    Eur Urol; 2004 Oct; 46(4):496-501; discussion 501-2. PubMed ID: 15363567
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transurethral ethanol ablation of the prostate for symptomatic benign prostatic hyperplasia: long-term follow-up.
    El-Husseiny T; Buchholz N
    J Endourol; 2011 Mar; 25(3):477-80. PubMed ID: 21355774
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bipolar plasma enucleation of the prostate vs open prostatectomy in large benign prostatic hyperplasia cases - a medium term, prospective, randomized comparison.
    Geavlete B; Stanescu F; Iacoboaie C; Geavlete P
    BJU Int; 2013 May; 111(5):793-803. PubMed ID: 23469933
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Feasibility of holmium laser enucleation of the prostate (HoLEP) for recurrent/residual benign prostatic hyperplasia (BPH).
    Elshal AM; Elmansy HM; Elhilali MM
    BJU Int; 2012 Dec; 110(11 Pt C):E845-50. PubMed ID: 22702908
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Percutaneous ethanol injection of the prostate as minimally invasive treatment for benign prostatic hyperplasia: preliminary report.
    Savoca G; De Stefani S; Gattuccio I; Paolinelli D; Stacul F; Belgrano E
    Eur Urol; 2001 Nov; 40(5):504-8. PubMed ID: 11752856
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transurethral ethanol ablation of the prostate (TEAP): an effective minimally invasive treatment alternative to traditional surgery for symptomatic benign prostatic hyperplasia (BPH) in high-risk comorbidity patients.
    Magno C; Mucciardi G; Galì A; Anastasi G; Inferrera A; Morgia G
    Int Urol Nephrol; 2008; 40(4):941-6. PubMed ID: 18478352
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transurethral ethanol injection for prostatic obstruction: an excellent treatment strategy for persistent urinary retention.
    Mutaguchi K; Matsubara A; Kajiwara M; Hanada M; Mizoguchi H; Ohara S; Yasumoto H; Usui T
    Urology; 2006 Aug; 68(2):307-11. PubMed ID: 16904442
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intraprostatic botulinum neurotoxin type a injection for benign prostatic hyperplasia: preliminary results with a newly purified neurotoxin.
    Yokoyama T; Yamamoto Y; Suzuki T; Oguma K; Nagai A
    Acta Med Okayama; 2012; 66(4):291-7. PubMed ID: 22918201
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transurethral ethanol injection therapy for prostatic hyperplasia: 3-year results.
    Goya N; Ishikawa N; Ito F; Kobayashi C; Tomizawa Y; Toma H
    J Urol; 2004 Sep; 172(3):1017-20. PubMed ID: 15311027
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prostatic tissue ablation by injection: a literature review.
    Plante MK; Folsom JB; Zvara P
    J Urol; 2004 Jul; 172(1):20-6. PubMed ID: 15201730
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparative study of thulium laser resection of the prostate and bipolar transurethral plasmakinetic prostatectomy for treating benign prostatic hyperplasia.
    Peng B; Wang GC; Zheng JH; Xia SQ; Geng J; Che JP; Yan Y; Huang JH; Xu YF; Yang B
    BJU Int; 2013 Apr; 111(4):633-7. PubMed ID: 23107074
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Intraprostatic injection of 96% ethanol in experimental animal model].
    Martov AG; Pavlov DA; Kirpatovskiĭ VI; Kudriavtsev IuV
    Urologiia; 2004; (6):21-6. PubMed ID: 15719725
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ethanol injection for the treatment of benign prostatic hyperplasia.
    Kim ED
    Curr Urol Rep; 2002 Aug; 3(4):276-9. PubMed ID: 12149157
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A prospective, randomized 1-year clinical trial comparing transurethral needle ablation to transurethral resection of the prostate for the treatment of symptomatic benign prostatic hyperplasia.
    Bruskewitz R; Issa MM; Roehrborn CG; Naslund MJ; Perez-Marrero R; Shumaker BP; Oesterling JE
    J Urol; 1998 May; 159(5):1588-93; discussion 1593-4. PubMed ID: 9554360
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.